Skye Bioscience Inc
Filed Mar 27, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Mar 27, 2024
Contents
Experts
Marcum LLP, an independent registered public accounting firm, has audited our consolidated financial statements included in this Registration Statement for the years ended December 31, 2023 and 2022, as set forth in its report, which is included in this prospectus and the registration statement. Such financial statements are including in this prospectus and the registration statement in reliance on Marcum LLP’s report, given on the authority of said firm as experts in accounting and auditing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.